Fasting venous blood collected from 83 patients with breast cancer was analyzed for triglycerides; total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol; tumor necrosis factor (TNFa); glucose; creatinine; insulin; glucagon; growth hormone; cortisol; and thyrotropin. Patients with stage IV disease had sig-nificantly higher (P <0.05) triglyceride concentrations and significantly lower (P <005) concentrations of total and HDL cholesterol than did patients with less advanced disease or age-matched controls. Furthermore, LDL cho-lesterol concentrations in patients with boney metastases were significantly lower (P <0.05) than concentrations in patients with liver or liver plus boney metastases or in control...
Heart disease is a leading cause of death in the United States and has consequently sparked ...
<div><p>Purpose</p><p>Epidemiologic studies exploring causal associations between serum lipids and b...
In a comparative study of pre- and postmenopausal women with benign and malignant breast disease, a ...
Serum triglycerides, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL...
The relationship between lipid levels and breast cancer in women has given conflicting results and i...
Epidemiological evidence suggests that dietary fat may be an aetiological factor for breast cancer. ...
International audiencePURPOSE:Several mechanistic studies support a role of cholesterol or its metab...
190-194The changes in the levels of MDA, nitrite, vit. E, lipids (total cholesterol and triglyceride...
Epidemiologic evidence indicates a role for cholesterol in breast cancer; however the precise mechan...
SUMMARY. Fasting blood samples were collected from 83 patients with histologically proven breast can...
Abstract Background Research on the impact of metabolic abnormalities on breast cancer prognosis is ...
Background Breast cancer treatment has metabolic side effects, potentially affecting risk of cardiov...
Breast cancer is the most prevalent cancer and primary cause of cancer-related mortality in women. T...
Breast cancer is one of the main leading causes of women death. In recent years, attention has been ...
Changes in cellular lipid metabolism are a common feature in most solid tumors, which occur already ...
Heart disease is a leading cause of death in the United States and has consequently sparked ...
<div><p>Purpose</p><p>Epidemiologic studies exploring causal associations between serum lipids and b...
In a comparative study of pre- and postmenopausal women with benign and malignant breast disease, a ...
Serum triglycerides, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL...
The relationship between lipid levels and breast cancer in women has given conflicting results and i...
Epidemiological evidence suggests that dietary fat may be an aetiological factor for breast cancer. ...
International audiencePURPOSE:Several mechanistic studies support a role of cholesterol or its metab...
190-194The changes in the levels of MDA, nitrite, vit. E, lipids (total cholesterol and triglyceride...
Epidemiologic evidence indicates a role for cholesterol in breast cancer; however the precise mechan...
SUMMARY. Fasting blood samples were collected from 83 patients with histologically proven breast can...
Abstract Background Research on the impact of metabolic abnormalities on breast cancer prognosis is ...
Background Breast cancer treatment has metabolic side effects, potentially affecting risk of cardiov...
Breast cancer is the most prevalent cancer and primary cause of cancer-related mortality in women. T...
Breast cancer is one of the main leading causes of women death. In recent years, attention has been ...
Changes in cellular lipid metabolism are a common feature in most solid tumors, which occur already ...
Heart disease is a leading cause of death in the United States and has consequently sparked ...
<div><p>Purpose</p><p>Epidemiologic studies exploring causal associations between serum lipids and b...
In a comparative study of pre- and postmenopausal women with benign and malignant breast disease, a ...